Therapeutic angiogenesis using hepatocyte growth factor (HGF)

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Cell Biology

Background:

• Hepatocyte growth factor (HGF) is a pleiotropic factor regulating cell growth, motility, and morphogenesis.
• HGF mediates epithelial-mesenchymal interactions crucial for embryonic development and organogenesis.
• HGF is recognized as an angiogenic growth factor with its receptor, c-met, present in vascular and cardiac cells.

Purpose of the Study:

• To review the therapeutic potential of HGF in cardiovascular diseases.
• To discuss HGF as a treatment strategy for conditions like peripheral vascular disease, myocardial infarction, and cerebrovascular disease.

Main Methods:

• Literature review of studies on HGF and cardiovascular applications.
• Analysis of HGF's role in angiogenesis and endothelial cell mitogenesis.
• Examination of c-met receptor expression in cardiovascular tissues.

Main Results:

• HGF exhibits potent mitogenic effects on human endothelial cells, surpassing other growth factors.
• HGF's receptor, c-met, is expressed in vascular and cardiac myocytes.
• Preclinical studies suggest HGF's efficacy in treating various cardiovascular diseases.

Conclusions:

• HGF represents a promising therapeutic agent for cardiovascular diseases due to its angiogenic and regenerative properties.
• Further research into HGF-based therapies could revolutionize cardiovascular disease treatment.
• Targeting the HGF/c-met pathway offers a novel strategy for cardiovascular regeneration.